Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine monotherapy for children with paroxysmal kinesigenic dyskinesia
ChiCTR-OPC-15006294Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lamotrigine in paroxysmal kinesigenic dyskinesia (PKD), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Frequency of attack. Started May 2015; status: recruiting.
02
Drugs
lamotrigine
03
Conditions
paroxysmal kinesigenic dyskinesia (PKD)
Beyond the preview
Go deeper on ChiCTR-OPC-15006294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006294.